Scott Dahlbeck - 23 May 2022 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBPQ)

Role
Chief Medical Officer
Signature
/s/ Scott Dahlbeck
Issuer symbol
KRBPQ
Transactions as of
23 May 2022
Net transactions value
$0
Form type
4
Filing time
25 May 2022, 16:15:43 UTC
Next filing
15 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRBP Common Stock Options Exercise +17,240 +4% 446,757 23 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRBP Restricted Stock Units Options Exercise $0 -17,240 -100% $0.000000* 0 23 May 2022 Common Stock 17,240 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On August 20, 2020, the reporting person was granted 17,420 restricted stock units, vesting on October 16, 2021.